LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_000314.8:c.18A>C
PTEN
· NP_000305.3:p.(Lys6Asn)
· NM_000314.8
GRCh37: chr10:89624244 A>C
·
GRCh38: chr10:87864487 A>C
Gene:
PTEN
Transcript:
NM_000314.8
Final call
VUS
PM2 supporting
PP2 supporting
BP4 supporting
Variant details
Gene
PTEN
Transcript
NM_000314.8
Protein
NP_000305.3:p.(Lys6Asn)
gnomAD AF
ClinVar
Uncertain significance
OncoKB
Likely Oncogenic
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PM2 supporting: the variant is absent from gnomAD v2.1 and v4.1.
2
PP2 supporting: p.Lys6Asn is a missense variant covered by the PTEN VCEP PP2 specification.
3
BP4 supporting: the REVEL score is 0.489, below the PTEN VCEP cutoff of 0.5.
Final determination:
Under the PTEN VCEP Version 3.2 combining rules, the applied PM2, PP2, and BP4 supporting criteria satisfy neither a pathogenic rule nor a benign rule, so the variant is classified as VUS.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: c.18A>C is a missense substitution, whereas the PTEN PVS1 decision tree covers specified loss-of-function consequence classes. |
cspec
vcep_pvs1_decisiontree_pten
|
| PS1 | Not assessed | Not assessed: no verified previously established pathogenic variant with the same p.Lys6Asn amino-acid change was available, and comparator retrieval had a documented soft failure. |
cspec
clinvar
pm5_candidates
|
| PS2 | Not assessed | Not assessed: no proband-level de novo observation, parental testing, maternity/paternity confirmation, or family-history information is available. |
cspec
|
| PS3 | Not met | Not met: high-confidence K6N Cum_score was -1.045273268, above the PTEN VCEP PS3_Moderate cutoff of <= -1.11. |
vcep_mmc2
PMID:29706350
PMID:27147599
|
| PS4 | Not assessed | Not assessed: no case-control statistics or phenotype-specificity score are available to compare with the VCEP's PS4 requirements. |
cspec
|
| PM1 | Not met | Not met: p.Lys6Asn is at residue 6, outside VCEP catalytic motifs 90-94, 123-130, and 166-168, with no statistically significant hotspot reported. |
cspec
|
| PM2 | Met | Met at Supporting: the variant is absent from gnomAD v2.1 and v4.1, satisfying the PTEN VCEP PM2 threshold of <0.00001 (0.001%). |
cspec
gnomad_v2
gnomad_v4
|
| PM3 | N/A | Not applicable: the PTEN VCEP explicitly marks PM3 “Not Applicable.” |
cspec
|
| PM4 | N/A | Not applicable: p.(Lys6Asn) is a missense substitution with no protein-length change, not an in-frame indel or stop-loss variant. |
cspec
|
| PM5 | Not assessed | Not assessed: no qualifying pathogenic or likely pathogenic alternate missense at Lys6 was verified, and the required BLOSUM62 comparison is unavailable. |
cspec
pm5_candidates
|
| PM6 | Not assessed | Not assessed: zero documented presumed or assumed de novo observations and no disease or family-history data are available. |
cspec
|
| PP1 | Not assessed | Not assessed: no affected relatives, co-segregation observations, or meiosis count are documented for this variant. |
cspec
|
| PP2 | Met | Met at supporting strength: p.Lys6Asn is a missense variant, and the PTEN VCEP specifies PP2 for PTEN's low benign-missense rate and common missense disease mechanism. |
cspec
|
| PP3 | Not met | Not met: the missense REVEL score is 0.489, below the PTEN VCEP PP3 threshold of greater than 0.7. |
cspec
revel
|
| PP4 | N/A | Not applicable: the PTEN VCEP incorporates phenotype specificity into PS4 rather than allowing independent PP4 use. |
cspec
|
| PP5 | N/A | Not applicable: the PTEN VCEP explicitly prohibits use of PP5 under its specification. |
cspec
|
| BA1 | Not met | Not met: the variant is absent from gnomAD v2.1 and v4.1, rather than exceeding the BA1 threshold of >0.00056 (0.056%). |
cspec
gnomad_v2
gnomad_v4
|
| BS1 | Not met | Not met: no gnomAD allele frequency was observed, so the variant does not fall within either BS1 interval from 0.0000043 to 0.00056. |
cspec
gnomad_v2
gnomad_v4
|
| BS2 | Not met | Not met: gnomAD v2.1 and v4.1 report zero observed alleles, providing no homozygous healthy-individual observation required for BS2. |
cspec
gnomad_v2
gnomad_v4
|
| BS3 | Not met | Not met: high-confidence K6N Cum_score was -1.045273268, not greater than the PTEN VCEP BS3_Supporting threshold of >0. |
vcep_mmc2
PMID:29706350
PMID:27147599
|
| BS4 | Not assessed | Not assessed: no affected-family testing or lack-of-segregation observation is documented in one or more families. |
cspec
|
| BP1 | N/A | Not applicable: the PTEN VCEP explicitly marks BP1 as Not Applicable. |
cspec
|
| BP2 | Not assessed | Not assessed: no cis/trans or phase information links this variant to a different pathogenic or likely pathogenic PTEN variant. |
cspec
clinvar
|
| BP3 | N/A | Not applicable: the PTEN VCEP explicitly marks BP3 as Not Applicable, and this variant is a missense substitution. |
cspec
|
| BP4 | Met | Met: the missense REVEL score is 0.489, below the PTEN VCEP BP4 threshold of less than 0.5. |
cspec
revel
|
| BP5 | Not assessed | Not assessed: no two qualifying cases with a highly penetrant alternate disorder and non-overlapping PTEN history are documented. |
cspec
|
| BP6 | N/A | Not applicable: the PTEN VCEP explicitly prohibits use of BP6 under its specification. |
cspec
|
| BP7 | N/A | Not applicable: c.18A>C is an exonic missense variant, whereas PTEN VCEP BP7 covers only synonymous or intronic variants at or beyond +7/-21. |
cspec
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.